Pakieli H. Kaufusi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pakieli H. Kaufusi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alanna C. Tseng
Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Mānoa, Honolulu, HI 96813, USA
3 shared publications - Vivek Ramchandra Nerurkar
Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A Burns School of Medicine, University of Hawaii at Manoa, Honolulu, HI 96813, USA
3 shared publications - Helmut Kae
Science Department, Leeward Community College, University of Hawaii, Pearl City, HI 96782, USA
2 shared publications - Kabi R. Neupane
Division of Math and Sciences, Leeward Community College, Pearl City, HI 96782, USA
2 shared publications Alanna Tseng
Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, 651 Ilalo Street, BSB 320, Honolulu, HI, 96813, USA
1 shared publication- Deniz Bicakci
Daniel K. Inouye College of Pharmacy, University of Hawai‘i at Hilo, Hilo, Hawai‘i
1 shared publication
Latest Publications
- Open Access
- 6 May 2026
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 114 (5) , 930-936
An Outbreak of Neuroangiostrongyliasis (Rat Lungworm Disease) in Hawai‘i: Evidence Supporting the Early Use of Albendazole–Corticosteroid Co-Therapy
: Neuroangiostrongyliasis (NAS) is an emerging parasitic infection caused by the neurotropic nematode Angiostrongylus cantonensis ( A. cantonensis ). It is the leading infectious etiology of eosinophilic meningitis worldwide. In 2017, six men living on Hawai‘i Island developed NAS after drinking homemade kava. After the event, a dead slug, likely infected with A. cantonensis , was found at the bottom of a communal vessel. Neuroangiostrongyliasis was subsequently confirmed in three patients through polymerase chain reaction testing of their cerebrospinal fluid. Two patients were presumptively diagnosed with NAS on the basis of highly suggestive signs and symptoms, the presence of eosinophilic meningitis, and a shared history of exposure. A lumbar puncture was unsuccessful in one patient, who was presumptively diagnosed with NAS on the basis of his symptoms and shared exposure history. Five of six patients received at least 2 weeks of co-therapy with albendazole and corticosteroids, which was initiated within 15 days of infection. The treatment was well-tolerated, and no significant adverse events were noted. One patient who did not have health insurance completed only two doses of albendazole because of the cost of the drug and experienced symptom recurrence on several occasions. This rare, common-source outbreak of A. cantonensis infection supports the early use of albendazole–corticosteroid co-therapy in proven or suspected cases of NAS. It also provides additional evidence for the water transmissibility of this parasite.
- 6 May 2026
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 114 (5) , 930-936
Open AccessAn Outbreak of Neuroangiostrongyliasis (Rat Lungworm Disease) in Hawai‘i: Evidence Supporting the Early Use of Albendazole–Corticosteroid Co-Therapy
: Neuroangiostrongyliasis (NAS) is an emerging parasitic infection caused by the neurotropic nematode Angiostrongylus cantonensis ( A. cantonensis ). It is the leading infectious etiology of eosinophilic meningitis worldwide. In 2017, six men living on Hawai‘i Island developed NAS after drinking homemade kava. After the event, a dead slug, likely infected with A. cantonensis , was found at the bottom of a communal vessel. Neuroangiostrongyliasis was subsequently confirmed in three patients through polymerase chain reaction testing of their cerebrospinal fluid. Two patients were presumptively diagnosed with NAS on the basis of highly suggestive signs and symptoms, the presence of eosinophilic meningitis, and a shared history of exposure. A lumbar puncture was unsuccessful in one patient, who was presumptively diagnosed with NAS on the basis of his symptoms and shared exposure history. Five of six patients received at least 2 weeks of co-therapy with albendazole and corticosteroids, which was initiated within 15 days of infection. The treatment was well-tolerated, and no significant adverse events were noted. One patient who did not have health insurance completed only two doses of albendazole because of the cost of the drug and experienced symptom recurrence on several occasions. This rare, common-source outbreak of A. cantonensis infection supports the early use of albendazole–corticosteroid co-therapy in proven or suspected cases of NAS. It also provides additional evidence for the water transmissibility of this parasite.
- Open Access
Membrane Retention of West Nile Virus NS5 Depends on NS1 or NS3 for Enzymatic Activity
West Nile virus (WNV) nonstructural protein 5 (NS5) possesses multiple enzymatic domains essential for viral RNA replication. During infection, NS5 predominantly localizes to unique replication organelles (ROs) at the rough endoplasmic reticulum (RER), known as vesicle packets (VPs) and convoluted membranes (CMs), with a portion of NS5 accumulating in the nucleus. NS5 is a soluble protein that must be in the VP, where its enzymatic activities are required for viral RNA synthesis. However, the mechanistic processes behind the recruitment of NS5 from the cytoplasm to the RER membrane remain unclear. Here, we utilize high-resolution confocal microscopy and sucrose density gradient ultracentrifugation to investigate whether the association of NS5 with other NS proteins contributes to its membrane recruitment and retention. We demonstrate that NS1 or NS3 partially influences the NS5 association with the membrane. We further demonstrate that processed NS5 is predominantly in the cytoplasm and nucleus, indicating that the processing of NS5 from the viral polyprotein does not contribute to its membrane localization. These observations suggest that other host or viral factors, such as the enwrapment of NS5 by the RO, may also be necessary for the complete membrane retention of NS5. Therefore, studies on the inhibitors that disrupt the membrane localization of WNV NS5 are warranted for antiviral drug development.
Open AccessMembrane Retention of West Nile Virus NS5 Depends on NS1 or NS3 for Enzymatic Activity
West Nile virus (WNV) nonstructural protein 5 (NS5) possesses multiple enzymatic domains essential for viral RNA replication. During infection, NS5 predominantly localizes to unique replication organelles (ROs) at the rough endoplasmic reticulum (RER), known as vesicle packets (VPs) and convoluted membranes (CMs), with a portion of NS5 accumulating in the nucleus. NS5 is a soluble protein that must be in the VP, where its enzymatic activities are required for viral RNA synthesis. However, the mechanistic processes behind the recruitment of NS5 from the cytoplasm to the RER membrane remain unclear. Here, we utilize high-resolution confocal microscopy and sucrose density gradient ultracentrifugation to investigate whether the association of NS5 with other NS proteins contributes to its membrane recruitment and retention. We demonstrate that NS1 or NS3 partially influences the NS5 association with the membrane. We further demonstrate that processed NS5 is predominantly in the cytoplasm and nucleus, indicating that the processing of NS5 from the viral polyprotein does not contribute to its membrane localization. These observations suggest that other host or viral factors, such as the enwrapment of NS5 by the RO, may also be necessary for the complete membrane retention of NS5. Therefore, studies on the inhibitors that disrupt the membrane localization of WNV NS5 are warranted for antiviral drug development.
- Open Access
Potential Dual Role of West Nile Virus NS2B in Orchestrating NS3 Enzymatic Activity in Viral Replication
West Nile virus (WNV) nonstructural protein 3 (NS3) harbors the viral triphosphatase and helicase for viral RNA synthesis and, together with NS2B, constitutes the protease responsible for polyprotein processing. NS3 is a soluble protein, but it is localized to specialized compartments at the rough endoplasmic reticulum (RER), where its enzymatic functions are essential for virus replication. However, the mechanistic details behind the recruitment of NS3 from the cytoplasm to the RER have not yet been fully elucidated. In this study, we employed immunofluorescence and biochemical assays to demonstrate that NS3, when expressed individually and when cleaved from the viral polyprotein, is localized exclusively to the cytoplasm. Furthermore, NS3 appeared to be peripherally recruited to the RER and proteolytically active when NS2B was provided in trans. Thus, we provide evidence for a potential additional role for NS2B in not only serving as the cofactor for the NS3 protease, but also in recruiting NS3 from the cytoplasm to the RER for proper enzymatic activity. Results from our study suggest that targeting the interaction between NS2B and NS3 in disrupting the NS3 ER localization may be an attractive avenue for antiviral drug discovery.
Open AccessPotential Dual Role of West Nile Virus NS2B in Orchestrating NS3 Enzymatic Activity in Viral Replication
West Nile virus (WNV) nonstructural protein 3 (NS3) harbors the viral triphosphatase and helicase for viral RNA synthesis and, together with NS2B, constitutes the protease responsible for polyprotein processing. NS3 is a soluble protein, but it is localized to specialized compartments at the rough endoplasmic reticulum (RER), where its enzymatic functions are essential for virus replication. However, the mechanistic details behind the recruitment of NS3 from the cytoplasm to the RER have not yet been fully elucidated. In this study, we employed immunofluorescence and biochemical assays to demonstrate that NS3, when expressed individually and when cleaved from the viral polyprotein, is localized exclusively to the cytoplasm. Furthermore, NS3 appeared to be peripherally recruited to the RER and proteolytically active when NS2B was provided in trans. Thus, we provide evidence for a potential additional role for NS2B in not only serving as the cofactor for the NS3 protease, but also in recruiting NS3 from the cytoplasm to the RER for proper enzymatic activity. Results from our study suggest that targeting the interaction between NS2B and NS3 in disrupting the NS3 ER localization may be an attractive avenue for antiviral drug discovery.
- Open Access
Selective Reactivity of Anti-Japanese Encephalitis Virus NS4B Antibody Towards Different Flaviviruses
Studies investigating West Nile virus (WNV) NS4B protein function are hindered by the lack of an antibody recognizing WNV NS4B protein. Few laboratories have produced WNV NS4B antibodies, and none have been shown to work consistently. In this report, we describe a NS4B antibody against Japanese encephalitis virus (JEV) NS4B protein that cross-reacts with the NS4B protein of WNV but not of dengue virus (DENV). This JEV NS4B antibody not only recognizes WNV NS4B in infected cells, but also recognizes the NS4B protein expressed using transfection. It is evident from this data that the JEV NS4B antibody is specific to NS4B of WNV but not to NS4B of the four DENV serotypes. The specificity of this antibody may be due to the notable differences that exist between the amino acid sequence identity and antigenic relationships within the NS4B protein of the WNV, DENV, and JEV.
Open AccessSelective Reactivity of Anti-Japanese Encephalitis Virus NS4B Antibody Towards Different Flaviviruses
Studies investigating West Nile virus (WNV) NS4B protein function are hindered by the lack of an antibody recognizing WNV NS4B protein. Few laboratories have produced WNV NS4B antibodies, and none have been shown to work consistently. In this report, we describe a NS4B antibody against Japanese encephalitis virus (JEV) NS4B protein that cross-reacts with the NS4B protein of WNV but not of dengue virus (DENV). This JEV NS4B antibody not only recognizes WNV NS4B in infected cells, but also recognizes the NS4B protein expressed using transfection. It is evident from this data that the JEV NS4B antibody is specific to NS4B of WNV but not to NS4B of the four DENV serotypes. The specificity of this antibody may be due to the notable differences that exist between the amino acid sequence identity and antigenic relationships within the NS4B protein of the WNV, DENV, and JEV.
- 18 May 2016
- Published by Springer Nature
- Vol. 1435, 45-60
Functional Analysis of West Nile Virus Proteins in Human Cells
West Nile Virus (WNV) lineage 2 strains have been responsible for large outbreaks of neuroinvasive disease in the United States and Europe between 1999 and 2012. Different strains in this lineage have previously been shown to produce either severe or mild neuroinvasive disease in mice. Phylogenetic and amino acid comparisons between highly or less virulent lineage 2 strains have demonstrated that the nonstructural (NS) gene(s) were most variable. However, the roles of some of the NS proteins in virus life cycle are unknown. The aim of this chapter is to describe simple computational and experimental approaches that can be used to: (1) explore the possible roles of the NS proteins in virus life cycle and (2) test whether the subtle amino acid changes in WNV NS gene products contributed to the evolution of more virulent strains. The computational approaches include methods based on: (1) sequence similarity, (2) sequence motifs, and (3) protein membrane topology predictions. Highlighted experimental procedures include: (1) isolation of viral RNA from WNV-infected cells, (2) cDNA synthesis and PCR amplification of WNV genes, (3) cloning into GFP expression vector, (4) bacterial transformation, (5) plasmid isolation and purification, (6) transfection using activated dendrimers (Polyfect), and (7) immunofluorescence staining of transfected mammalian cells.
- 18 May 2016
- Published by Springer Nature
- Vol. 1435, 45-60
Functional Analysis of West Nile Virus Proteins in Human Cells
West Nile Virus (WNV) lineage 2 strains have been responsible for large outbreaks of neuroinvasive disease in the United States and Europe between 1999 and 2012. Different strains in this lineage have previously been shown to produce either severe or mild neuroinvasive disease in mice. Phylogenetic and amino acid comparisons between highly or less virulent lineage 2 strains have demonstrated that the nonstructural (NS) gene(s) were most variable. However, the roles of some of the NS proteins in virus life cycle are unknown. The aim of this chapter is to describe simple computational and experimental approaches that can be used to: (1) explore the possible roles of the NS proteins in virus life cycle and (2) test whether the subtle amino acid changes in WNV NS gene products contributed to the evolution of more virulent strains. The computational approaches include methods based on: (1) sequence similarity, (2) sequence motifs, and (3) protein membrane topology predictions. Highlighted experimental procedures include: (1) isolation of viral RNA from WNV-infected cells, (2) cDNA synthesis and PCR amplification of WNV genes, (3) cloning into GFP expression vector, (4) bacterial transformation, (5) plasmid isolation and purification, (6) transfection using activated dendrimers (Polyfect), and (7) immunofluorescence staining of transfected mammalian cells.